GRACEcast-111_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Socinski on TAILOR Trial in Advanced NSCLC
http://cancerGRACE.org/... Dr. Mark Socinski from University of Pittsburgh summarizes and critiques the TAILOR trial of Taxotere (docetaxel) vs. Tarceva (erlotinib) in EGFR wild type advanced NSCLC. Author: cancergrace Added: 01/17/2013 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts